Australia’s domestic vaccine capacity has taken a clear step forward with the opening of a major new cell-based vaccine manufacturing facility in Victoria. The Melbourne plant, operated by CSL Seqirus, is the first of its kind in the Southern Hemisphere and is being positioned as a cornerstone of the country’s long-term health security.
The facility will produce seasonal and pandemic influenza vaccines, antivenoms and the Q-Fever vaccine. These are products Australia has previously relied heavily on global supply chains for, especially during health emergencies when demand rises and international access can tighten.
Federal Health Minister Mark Butler and Victorian Minister for Economic Growth Danny Pearson formally opened the site, which follows a ten-year, one-billion-dollar agreement between the Commonwealth and CSL Seqirus to guarantee supply through to 2036. Victorian officials say the project adds momentum to a growing advanced manufacturing sector in the state, with more than 350 high-skilled roles expected to be created on site and further knock-on activity across the wider life-sciences industry.
The new plant is due to begin influenza vaccine production at the start of next year, with antivenoms and Q-Fever vaccines to follow mid-year. Melbourne will then host two major vaccine manufacturing sites, combining cell-based and mRNA capabilities in one city. Supporters of the move argue this places Australia on firmer footing if another pandemic hits, allowing faster and more reliable access to critical supplies.
Minister Butler said the ability to manufacture these products locally removes the risk of Australia standing in overseas queues during emergencies. Victorian representatives highlighted the state’s established strengths in research, biotech and medical manufacturing, positioning the project as a logical expansion of that ecosystem.
CSL Seqirus leadership described the opening as part of a long track record of vaccine innovation, pointing to more than a century of work in this field. While the investment is being welcomed across government and industry, observers will be watching whether the plant meets its production timelines and delivers the scale needed to match Australia’s expectations for domestic resilience.
This development sits within a broader national push to strengthen onshore medical manufacturing, following recent moves to establish mRNA production in Australia. Together, the facilities give policymakers more control over supply during periods of global uncertainty, though long-term performance and cost-efficiency will remain key tests.
Support independent community journalism. Support The Indian Sun.
Follow The Indian Sun on X | Instagram | Facebook
Support Independent Community Journalism
Dear Reader,The Indian Sun exists for one reason: to tell stories that might otherwise go unheard.
We report on local councils, state politics, small businesses and cultural festivals. We focus on the Indian diaspora and the wider multicultural community with care, balance and accountability. We publish in print and online, send regular newsletters and produce video content. We also run media training programs to help community organisations share their own stories.
We operate independently.
Community journalism does not have the backing of large media corporations. Advertising revenue fluctuates. Platform algorithms change. Costs continue to rise. Yet the need for credible, grounded reporting in a multicultural Australia has never been greater.
When you support The Indian Sun, you support:
• Independent reporting on issues affecting migrant communities
• Coverage of local and state decisions that shape daily life
• A platform for small businesses and community groups
• Media training that builds skills within the community
• Journalism accountable to readers
We cannot cover everything, but we work to cover what matters.
If you value thoughtful reporting that reflects Australia’s diversity, we invite you to contribute. Every donation helps us maintain the quality and consistency of our work.
Please consider making a contribution today.
Thank you for your support.
The Indian Sun Team
